Declerck P - Search Results

1

Improved Potency and Safety of DNA-Encoded Antibody Therapeutics Through Plasmid Backbone and Expression Cassette Engineering.

Vermeire G, De Smidt E, Geukens N, Williams JA, Declerck P, Hollevoet K. Vermeire G, et al. Among authors: declerck p. Hum Gene Ther. 2021 Oct;32(19-20):1200-1209. doi: 10.1089/hum.2021.105. Hum Gene Ther. 2021. PMID: 34482757

2

Development of a universal anti-adalimumab antibody standard for interlaboratory harmonization.

Gils A, Vande Casteele N, Poppe R, Van de Wouwer M, Compernolle G, Peeters M, Brouwers E, Vermeire S, Geukens N, Declerck PJ. Gils A, et al. Ther Drug Monit. 2014 Oct;36(5):669-73. doi: 10.1097/FTD.0000000000000074. Ther Drug Monit. 2014. PMID: 24906181 Free PMC article.

3

Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays.

Van Stappen T, Brouwers E, Tops S, Geukens N, Vermeire S, Declerck PJ, Gils A. Van Stappen T, et al. Ther Drug Monit. 2015 Aug;37(4):479-85. doi: 10.1097/FTD.0000000000000162. Ther Drug Monit. 2015. PMID: 25525757

4

State of play and clinical prospects of antibody gene transfer.

Hollevoet K, Declerck PJ. Hollevoet K, et al. J Transl Med. 2017 Jun 7;15(1):131. doi: 10.1186/s12967-017-1234-4. J Transl Med. 2017. PMID: 28592330 Free PMC article. Review.

5

Prolonged in vivo expression and anti-tumor response of DNA-based anti-HER2 antibodies.

Hollevoet K, De Smidt E, Geukens N, Declerck P. Hollevoet K, et al. Among authors: declerck p. Oncotarget. 2018 Feb 6;9(17):13623-13636. doi: 10.18632/oncotarget.24426. eCollection 2018 Mar 2. Oncotarget. 2018. PMID: 29568382 Free PMC article.

6

Bridging the Clinical Gap for DNA-Based Antibody Therapy Through Translational Studies in Sheep.

Hollevoet K, De Vleeschauwer S, De Smidt E, Vermeire G, Geukens N, Declerck P. Hollevoet K, et al. Among authors: declerck p. Hum Gene Ther. 2019 Nov;30(11):1431-1443. doi: 10.1089/hum.2019.128. Epub 2019 Sep 10. Hum Gene Ther. 2019. PMID: 31382777

7

DNA-Based Delivery of Checkpoint Inhibitors in Muscle and Tumor Enables Long-Term Responses with Distinct Exposure.

Jacobs L, De Smidt E, Geukens N, Declerck P, Hollevoet K. Jacobs L, et al. Among authors: declerck p. Mol Ther. 2020 Apr 8;28(4):1068-1077. doi: 10.1016/j.ymthe.2020.02.007. Epub 2020 Feb 13. Mol Ther. 2020. PMID: 32101701 Free PMC article.

8

Expanding a Portfolio of (FO-) SPR Surface Chemistries with the Co(III)-NTA Oriented Immobilization of His₆-Tagged Bioreceptors for Applications in Complex Matrices.

Qu JH, Horta S, Delport F, Sillen M, Geukens N, Sun DW, Vanhoorelbeke K, Declerck P, Lammertyn J, Spasic D. Qu JH, et al. Among authors: declerck p. ACS Sens. 2020 Apr 24;5(4):960-969. doi: 10.1021/acssensors.9b02227. Epub 2020 Apr 8. ACS Sens. 2020. PMID: 32216277

9

DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration.

Vermeire G, De Smidt E, Casteels P, Geukens N, Declerck P, Hollevoet K. Vermeire G, et al. Among authors: declerck p. Cancer Gene Ther. 2021 Aug;28(7-8):828-838. doi: 10.1038/s41417-020-0204-9. Epub 2020 Jul 30. Cancer Gene Ther. 2021. PMID: 32733055

10

Electroporation outperforms in vivo-jetPEI for intratumoral DNA-based reporter gene transfer.

Jacobs L, De Smidt E, Geukens N, Declerck P, Hollevoet K. Jacobs L, et al. Among authors: declerck p. Sci Rep. 2020 Nov 11;10(1):19532. doi: 10.1038/s41598-020-75206-2. Sci Rep. 2020. PMID: 33177564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters